Kevin Kobielski

Kevin Kobielski

Why Carve-Outs Happen And How To Prevent Them

See this article by AlignRx CEO Kevin Kobielski as it originally ran in Healthcare Business Today.  Carve-outs can be a thorn in the side of health plans. But with a little creative thinking in key areas, insurers can solve the problems that cause employer groups to rely on carve-outs.  For employers, the appeal of carve-outs […]

Why Carve-Outs Happen And How To Prevent Them Read More »

AlignRx Highlighted on Self-Funded with Spencer Podcast

Brian Shonat, Goodroot’s area vice president of business development, recently joined Spencer Smith on the Self-Funded with Spencer podcast to talk AlignRx, PBM contracts, specialty drugs and more. Below are some of the highlights of what Brian had to say during the hour-long chat.  Listen to the full episode on the Self-Funded with Spencer podcast. 

AlignRx Highlighted on Self-Funded with Spencer Podcast Read More »

Webinar on Demand: Meeting the Mandate—The TPA Path to RxDC Success

The RxDC Reporting Deadline is Approaching—Are you Prepared? At AlignRx, we provide our valued TPA partners and their employer groups with year-round pharmacy consulting and expertise. The RxDC mandate is no exception. We covered: PBM timelines—and how they impact yours Understanding PBM charges for data submission communicating them with your clients Rebates, rebates, rebates! Ensuring

Webinar on Demand: Meeting the Mandate—The TPA Path to RxDC Success Read More »

RxDC TPA Guide – What TPAs Need to Know

The RxDC Reporting Deadline Is Approaching—Are You Prepared? The Consolidated Appropriations Act has a new Rx mandate for your employer groups and the deadline is approaching—are you prepared? The new mandate requires employer-based health plans to submit information about prescription drug and healthcare spending to the Departments of Health & Human Services, Labor, and the

RxDC TPA Guide – What TPAs Need to Know Read More »

How Specialty Drug ‘Solution Stacking’ Can Rein in Pharmacy Benefit Costs

Brokers and employer groups alike know that 5% to 10% percent of insured workers and their dependents drive 50% to 60% of the cost of pharmacy claims. A few members with prescriptions for a specialty drug with a five-figure price tag can easily represent the majority of an entire group’s pharmacy spend. These drugs are

How Specialty Drug ‘Solution Stacking’ Can Rein in Pharmacy Benefit Costs Read More »